SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...

Evolus dermal filler, Evolysse™ Lift, met primary endpoint of non-inferiority and demonstrated superiority to Restylane-L at 6 months; Secondary endpoints for improvement in nasolabial fold severity ...

The Medtronic investment and the underwritten public offering of common stock position Anteris to continue to execute the global PARADIGM Trial and to continue investing in research that can transform ...

SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to ...

Multiple cohorts now report excellent mid- and long-term survivorship for cementless total knee arthroplasty systems using 3D ...

On January 20, the Russian military launched a massive combined arms strike on the Neo-Nazi junta, hitting hundreds of ...

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

Concept Medical has enrolled the first patients in the STARS DAPT global trial evaluating its polymer-free Abl ...

AI/ML are driving a steep ramp in neural processing unit (NPU) design activity for everything from data centers to edge ...

Enzymes with specific functions are becoming increasingly important in industry, medicine and environmental protection. For example, they make it possible to synthesize chemicals in a more ...

Background:Dementia represents a major global public health challenge, affecting over 55 million people worldwide and projected to increase substantially in ...